Envestnet Asset Management Inc Supernus Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

  • $299 Billion
  • Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 60,269 shares of SUPN stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,269
Previous 59,970 0.5%
Holding current value
$2.01 Million
Previous $2.17 Million 8.99%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
BUY
$31.17 - $40.0 $9,319 - $11,960
299 Added 0.5%
60,269 $1.97 Million
Q4 2024

Feb 12, 2025
BUY
$31.89 - $37.83 $111,455 - $132,215
3,495 Added 6.19%
59,970 $2.17 Million
Q3 2024

Nov 06, 2024
SELL
$25.77 - $35.16 $68,548 - $93,525
-2,660 Reduced 4.5%
56,475 $1.76 Million
Q2 2024

Aug 08, 2024
SELL
$25.99 - $33.85 $759,245 - $988,860
-29,213 Reduced 33.07%
59,135 $1.58 Million
Q1 2024

May 13, 2024
BUY
$27.11 - $35.17 $341,694 - $443,282
12,604 Added 16.64%
88,348 $3.01 Million
Q4 2023

Feb 13, 2024
SELL
$22.72 - $29.68 $85,972 - $112,309
-3,784 Reduced 4.76%
75,744 $2.19 Million
Q3 2023

Nov 13, 2023
SELL
$27.57 - $32.91 $112,430 - $134,206
-4,078 Reduced 4.88%
79,528 $2.19 Million
Q2 2023

Aug 04, 2023
SELL
$29.91 - $38.73 $11.2 Million - $14.4 Million
-372,809 Reduced 81.68%
83,606 $2.51 Million
Q1 2023

May 11, 2023
BUY
$34.93 - $42.03 $12.9 Million - $15.5 Million
369,806 Added 426.98%
456,415 $16.5 Million
Q4 2022

Feb 07, 2023
BUY
$31.09 - $37.88 $239,548 - $291,865
7,705 Added 9.77%
86,609 $3.09 Million
Q3 2022

Nov 10, 2022
BUY
$28.79 - $35.41 $180,916 - $222,516
6,284 Added 8.65%
78,904 $2.67 Million
Q2 2022

Aug 03, 2022
BUY
$25.33 - $34.25 $24,722 - $33,428
976 Added 1.36%
72,620 $2.1 Million
Q1 2022

May 04, 2022
BUY
$28.51 - $32.9 $94,510 - $109,063
3,315 Added 4.85%
71,644 $2.32 Million
Q4 2021

Feb 04, 2022
BUY
$26.37 - $34.22 $354,834 - $460,464
13,456 Added 24.52%
68,329 $1.99 Million
Q3 2021

Oct 07, 2021
BUY
$23.54 - $31.39 $143,570 - $191,447
6,099 Added 12.5%
54,873 $1.46 Million
Q2 2021

Aug 04, 2021
BUY
$26.72 - $33.19 $261,268 - $324,531
9,778 Added 25.07%
48,774 $1.5 Million
Q1 2021

May 04, 2021
BUY
$24.15 - $31.45 $607,203 - $790,747
25,143 Added 181.5%
38,996 $1.02 Million
Q4 2020

Feb 02, 2021
BUY
$17.7 - $25.81 $72,056 - $105,072
4,071 Added 41.62%
13,853 $349,000
Q3 2020

Oct 09, 2020
SELL
$20.2 - $25.05 $14,968 - $18,562
-741 Reduced 7.04%
9,782 $204,000
Q2 2020

Jul 08, 2020
SELL
$17.09 - $24.89 $9,792 - $14,261
-573 Reduced 5.16%
10,523 $250,000
Q1 2020

Apr 23, 2020
SELL
$14.45 - $24.69 $75,573 - $129,128
-5,230 Reduced 32.03%
11,096 $200,000
Q4 2019

Feb 11, 2020
SELL
$19.93 - $29.13 $217,396 - $317,750
-10,908 Reduced 40.05%
16,326 $387,000
Q3 2019

Oct 17, 2019
SELL
$25.47 - $33.37 $276,807 - $362,665
-10,868 Reduced 28.52%
27,234 $748,000
Q2 2019

Aug 02, 2019
SELL
$29.96 - $38.87 $16,238 - $21,067
-542 Reduced 1.4%
38,102 $1.26 Million
Q1 2019

May 10, 2019
BUY
$32.77 - $41.99 $30,148 - $38,630
920 Added 2.44%
38,644 $1.35 Million
Q4 2018

Feb 13, 2019
BUY
$30.84 - $49.51 $1.16 Million - $1.87 Million
37,724 New
37,724 $1.25 Million
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $657,836 - $871,209
-15,406 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$44.1 - $59.85 $35,544 - $48,239
-806 Reduced 4.97%
15,406 $922,000
Q1 2018

May 09, 2018
SELL
$37.15 - $46.9 $1.95 Million - $2.46 Million
-52,387 Reduced 76.37%
16,212 $743,000
Q4 2017

Feb 20, 2018
BUY
$36.4 - $42.6 $71,489 - $83,666
1,964 Added 2.95%
68,599 $2.73 Million
Q3 2017

Nov 13, 2017
SELL
$36.75 - $49.65 $144,868 - $195,720
-3,942 Reduced 5.59%
66,635 $2.67 Million
Q2 2017

Aug 14, 2017
BUY
N/A
70,577
70,577 $3.04 Million

Others Institutions Holding SUPN

# of Institutions
305
Shares Held
60.8M
Call Options Held
8.8K
Put Options Held
6.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.78B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email